Using surrogate markers in primary electronic patient record systems to confirm or refute the diagnosis of diabetes

Informatics in Primary Care

Volumn 17, Issue 2, 2009, Pages 121-129

  Bagheri, Ashkan ^e   Sadek, Ahmed ^a   Chan, Tom ^b   Khunti, Kamlesh ^c   De Lusignan, Simon ^d  

^a Academic Foundation Year 2 Doctor   (United States)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e NONE

Author keywords

Algorithms; Computer systems; Computerised; Controlled; Diabetes mellitus; Family practice; Medical informatics; Medical record systems; Vocabulary

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; BLOOD; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; HUMAN; LINGUISTICS; MEDICAL RECORD; METHODOLOGY; PREDICTION AND FORECASTING; PRIMARY HEALTH CARE; REVIEW; UNITED KINGDOM;

ALGORITHMS; BIOLOGICAL MARKERS; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; GREAT BRITAIN; HEALTH RECORDS, PERSONAL; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; VOCABULARY, CONTROLLED;

EID: 73949114242     PISSN: 14760320     EISSN: None     Source Type: Journal    
DOI: 10.14236/jhi.v17i2.724     Document Type: Article

References (30)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993;329:977-86. (Pubitemid 23307905)
2. York and Humber Public Health Observatory/National Diabetes Support Team. Diabetes Key Facts. 2006.
3. WHO Expert Committee on Diabetes Mellitus. Second report. WHO Technical Report Series 1980;646:1-80.
4. Baekkeskov S, Neilsen JH, Marner B, Bilde T, Ludvigsson J and Lernmark A. Autoantibodies in newly diagnosed diabetic children with immunoprecipitate human pancreatic islet cell proteins. Nature 1982;298: 167-9. (Pubitemid 12087509)
5. Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD and Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 1986; 35:894-8. (Pubitemid 16014441)
6. Marques RG, Fontaine MJ and Rogers J. C-peptide: much more than a byproduct of insulin biosynthesis. Pancreas 2004;29:231-8. (Pubitemid 39304981)
7. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS and Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995;44:790-5.
8. Redondo MJ, Rewers M, Yu L et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with Type 1A diabetes: prospective twin study. British Medical Journal 1999;318:698-702. (Pubitemid 29191993)
9. Atkinson MA and Eisenbarth GS. Type 1A diabetes: new perspectives on disease pathogenesis and treatment. The Lancet 2001;358:221-9. (Pubitemid 32718550)
10. Meyer L and Guerci B. Metformin and insulin in Type 1A diabetes: the first step. Diabetes Care 2003;26:1655-6. (Pubitemid 36929230)
11. Yorkshire and Humber Public Health Observatory. PBS Diabetes Population Prevalence Model. 2007. www.yhpho.org.uk/PBS-diabetes.aspx
12. Fajans SS, Bell GI and Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. New England Journal of Medicine 2001;345:971-80.
13. Lafusco D, Stazi MA, Cotichini R et al. Permanent diabetes mellitus in the first year of life. Diabetologia 2002;45:798-804.
14. Alberti KGMM. The clinical implications of impaired glucose tolerance. Diabetic Medicine 1996;13:927-37. (Pubitemid 26384115)
15. Shaw JE and Chisholm DJ. Epidemiology and prevention of Type 2 diabetes and the metabolic syndrome. Medical Journal of Australia 2003;179:379-83. (Pubitemid 37265135)
16. Petersen JL and McGuire DK. Impaired glucose tolerance and impaired fasting glucose: a review ofdiagnosis, clinical implications and management. Diabetes & Vascular Disease Research 2005;2:9-15.
17. O'Sullivan JB, Mahan CM, Charles D et al. Screening criteria for high-risk gestational diabetic patients. American Journal of Obstetrics and Gynecology 1973;116:895-900.
18. O'Sullivan J. The Boston Gestational Diabetes Studies: reviews and perspectives. In: Sutherland HW, Stowers JM, Pearson DWM (eds) Carbohydrate Metabolism in Pregnancy and the Newborn IV. Berlin: Springer-Verlag, 1989, pp. 287-94.
19. Scottish Intercollegiate Guidelines Network (SIGN). Management ofDiabetes: a national clinical guideline. 2001.
20. Scott DA, Loveman E, McIntyre L et al. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technology Assessment 2002;6:1-161.
21. Brody SC, Harris R and Lohr K. Screening for gestational diabetes: a summary of the evidence for the US Preventive Services Task Force. Obstetrics and Gynecology 2003; 101:380-92. (Pubitemid 36170141)
22. Marquette GP, Klein VR, Repke JT et al. Cost-effective criteria for glucose screening. Obstetrics and Gynecology 1985;66:181-4.
23. Dornhorst A, Paterson CM, Nicholls JSD et al. High prevalence ofgestational diabetes in women from ethnic minority groups. Diabetic Medicine 1992;9:820-5.
24. Moses RG. The recurrence rate of gestational diabetes in subsequent pregnancies. Diabetes Care 1996;19:1348- 50. (Pubitemid 26418613)
25. Berger H, Crane J and Farine D. Screening for gestational diabetes mellitus. Journal of Obstetrics and Gynaecology Canada 2002;24:894-912.
26. SOGC Committee. Routine Screening for Gestational Diabetes Mellitusin Pregnancy. SOGC Committee Opinion. No. 1, June 1992.
27. Avery MD and Walker AJ. Acute effect of exercise on blood glucose and insulin levels in women with gestational diabetes. Journal of Maternal-Fetal Medicine 2001;10:52-8. (Pubitemid 32510236)
28. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003;26 (Suppl 1):S103-S105.
29. Nelson KM and Boyko EJ. Predicting impaired glucose tolerance using common clinical information: data from the Third National Health and Nutrition Examination Survey. Diabetes Care 2003;26:2058-62.
30. Rollason W, Khunti K and de Lusignan S. Variation in the recording of diabetes diagnostic data in primary care computer systems: implications for the quality of care. Informatics in Primary Care 2009;17(2):113-9.